TDOC:CA:TSX-TD Global Healthcare Leaders Index ETF (CAD)

ETF | Others |

Last Closing

CAD 17.65

Change

+0.01 (+0.06)%

Market Cap

CAD 0.07B

Volume

3.98K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

-0.05 (-0.28%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.02 (+0.03%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.05 (-0.23%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

-0.03 (-0.10%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

+0.02 (+0.22%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

+0.04 (+0.29%)

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.02 (+0.09%)

CAD 2.78B

ETFs Containing TDOC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.14% 44% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.14% 43% F 39% F
Trailing 12 Months  
Capital Gain -0.68% 25% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.68% 23% F 32% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.86% 62% D 50% F
Dividend Return 1.86% 62% D 44% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.25% 71% C- 87% B+
Risk Adjusted Return 35.45% 72% C 62% D
Market Capitalization 0.07B 60% D- 32% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike